INTRODUCTION: In 2022, the National Aeronautics and Space Administration (NASA) began launching missions to establish a sustainable human presence on the Moon. One key to success will be maintaining human health. In preparation for longer missions with more diverse crews, the Spaceflight for Everybody Symposium was held to review currently known human spaceflight biomedical knowledge, the future of exploration space medicine, and the ability of NASA to manage the spaceflight human health risks and enable exploration. The symposium highlighted the future of precision health/personalized medicine, the possible spaceflight health acute and lifetime illnesses, and the challenge of identifying appropriate prevention, treatment, rehabilitation, and autonomous medical systems for long-duration spaceflight. The symposium was organized to look back at NASA exploration, science, and leadership successes, celebrate NASA women's leadership, and focus on future Artemis activities, including research and development that will benefit both spaceflight and terrestrial life. NASA current preparations for returning to the Moon have led to increased acknowledgment of the importance of workforce diversity, i.e., to use the best candidate in every work position, including the plan for the first woman and person of color to land on the Moon. NASA is developing plans to use commercial spaceflight research opportunities when the International Space Station is no longer available. Astronaut health decisions will consist of individualized health risk determinations and mitigation strategies and increased medical self-care. Research findings include improved exploration cardiovascular, musculoskeletal, and radiation risk reduction and improved interpersonal support for both astronaut crews and mission control personnel. Schneider V, Siegel B, Allen JR. Human health on the Moon and beyond and the results of the Spaceflight for Everybody Symposium . Aerosp Med Hum Perform. 2023; 94(8):634-643.
Keyphrases
- human health
- risk assessment
- climate change
- healthcare
- public health
- endothelial cells
- health risk
- heavy metals
- induced pluripotent stem cells
- pluripotent stem cells
- current status
- mental health
- intensive care unit
- type diabetes
- health information
- radiation therapy
- liver failure
- polycystic ovary syndrome
- health insurance
- pregnant women
- drinking water
- mass spectrometry